Publications

Communique from the 11th meeting of the Women's Health Products Working Group, 30 October 2025

Communique from the 4th meeting of the Human Research Ethics Committee and TGA Clinical Trials Discussion Forum, 1 December 2025

We conduct an annual stakeholder survey to improve the way we work with our stakeholders and help report on our key performance indicators.

The report includes data and feedback from the general public (consumers), people and organisations with a TGA business services account (opt-in stakeholders), and state and territory government representatives.

Advisory Committee on Complementary Medicines meeting statement for 31 July 2025

This web publication constitutes a notice for the purposes of regulation 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations).

Advisory Committee on Vaccines meeting statement 54

Medical device reforms: Consumer Working Group meeting statement, Meeting 17, 22 August 2025

Advisory Committee on Medicines meeting statement

The 87th meeting of the Advisory Committee on Medical Devices (ACMD) was held on 9 October 2025.

Communique from the 10th meeting of the WHPWG, 17 July 2025

Find out about the AIVC Recommendations for the Composition of Influenza Vaccines for Australia in 2026.

The Therapeutic Goods Administration (TGA) is issuing a safety advisory regarding imported unregistered melatonin products following testing by TGA Laboratories.

Publication of the decisions made by a delegate of the Secretary

In response to increased adverse event reports, the TGA has investigated Vyvanse products, which included laboratory testing to assess the quality of the 6 different strengths of Vyvanse products.

Communique from the 3rd meeting of the Human Research Ethics Committee and TGA Clinical Trials Discussion Forum, 13 August 2025

Advisory Committee on Complementary Medicines meeting statement for 6 March 2025

This study by the TGA assesses the particle filtration efficiency of respirators listed in the ARTG or submitted for compliance testing during the COVID-19 pandemic.

The 86th meeting of the Advisory Committee on Medical Devices (ACMD) was held on 14 August 2025.

Face masks that are intended by their manufacturer to prevent the transmission of diseases between people or are intended to be used in a healthcare environment, are medical devices

Advisory Committee on Medicines meeting statement

TGA laboratories Branch tested various seasonal influenza vaccine batches.

Between November 2024 and April 2025, TGA, Laboratories Branch tested various Heparin products

Advisory Committee on Vaccines meeting statement 53

This report summarises the extensive batch release testing activities undertaken by the TGA Laboratories for COVID-19 mRNA vaccines.

This survey focused on single-ingredient vitamin D3 products with high sales volumes in Australia between January and December 2023. The TGA tested 13 of the top-selling products, which were supplied by nine different sponsors.